ES: Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone
Study Details
Study Description
Brief Summary
All patients who were alive at the end of the dexamethasone treatment trial conducted by Oxford University CLinical Research Unit from 2001-2005 (n=340) will be eligible to participate in this long-term follow-up study.
All eligible and consenting patients will undergo an assesment consisting of a simple questionnaire, a clinical examination and a blood test. Data collected will focus on survival, neurological disability and tuberculosis relapse. Data will be collected in individual case record forms and entered into a computer database.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Survivors of TBM trial 2001-2005
|
Other: Observation
Collection of mortality data at 5 years post trial
|
Outcome Measures
Primary Outcome Measures
- Survival [5 years]
Secondary Outcome Measures
- Neurological disability [5 years]
- Tuberculosis relapse rate [5 years]
Eligibility Criteria
Criteria
Inclusion Criteria:Patients were alive at the end of the dexamethasone study (n=340) will be eligible to participate in this long-term follow-up study Informed consent
Exclusion Criteria:
Patients without informed consent
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Oxford University Clinical Research Unit, Vietnam
- Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
- Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
Investigators
- Principal Investigator: Estee Torok, MD, Oxford University Clinical Research Unit - Viet Nam
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ES